drugset / Trial / NCT00002919
Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer
Phase 2
Completed
30 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy following surgery in treating patients with stage II bladder cancer.
Timeline
- Start
- 1996-11
- Primary completion
- 2003-01
- Completion
- 2003-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Vinblastine | Small molecule | — | — |
| Background | filgrastim | Protein / enzyme biologic | — | Subcutaneous |